GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 3351 - 3375 of 4050 in total
Antibody Patient Onset (days) Symptom GlyTouCan ID ▼ Arbitrary Fluorescence Units (AFU)
IgG Patient 3 -180 mild
G14988WV
48
IgG Patient 3 11 mild
G14988WV
115
IgM Patient 3 -180 mild
G14988WV
87
IgA Patient 3 4 mild
G14988WV
527
IgG Patient 3 4 mild
G14988WV
120
IgM Patient 3 11 mild
G14988WV
372
IgM Patient 3 4 mild
G14988WV
423
IgA Patient 4 12 mild
G14988WV
621
IgG Patient 4 12 mild
G14988WV
253
IgM Patient 4 12 mild
G14988WV
808
IgA Patient 1 10 moderate
G14844CX
414
IgA Patient 1 22 moderate
G14844CX
389
IgA Patient 1 6 moderate
G14844CX
303
IgG Patient 1 10 moderate
G14844CX
27
IgG Patient 1 22 moderate
G14844CX
35
IgG Patient 1 6 moderate
G14844CX
24
IgM Patient 1 10 moderate
G14844CX
57
IgM Patient 1 22 moderate
G14844CX
174
IgM Patient 1 6 moderate
G14844CX
38
IgA Patient 2 15 mild
G14844CX
327
IgA Patient 2 24 mild
G14844CX
368
IgG Patient 2 15 mild
G14844CX
31
IgG Patient 2 24 mild
G14844CX
37
IgM Patient 2 15 mild
G14844CX
98
IgM Patient 2 24 mild
G14844CX
131

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024